Evidence and Benefit Map
Tools for a conversation.
For anyone concerned about memory, choices exist. This map puts 49 of the most common answers in one picture, so you can see at a glance what the research supports and how much benefit to expect.
Research is slow, still there is no reason to wait in pursuing small actions that may in total provide meaningful results. We're here to help when doing nothing is no longer an option.
How to read the map
- Each dot is one option. Dots lower on the map rest on stronger research; dots farther right promise a bigger benefit for the people they fit.
- Color sorts each option into one of three groups: worth discussing, test first, or not supported (see the key below).
- The right end of the bottom band (strong evidence, large benefit) is the most attractive zone.
- Tap, click or use the Tab key on any dot to see why it sits where it does and the research behind it.
The map
The 1 to 5 benefit scale
- 1 Negligible or no measurable effect
- 2 Small, mostly on blood markers or rating scales
- 3 Modest, possibly noticeable
- 4 Meaningful effect on thinking, daily function or dementia risk
- 5 Large, clearly meaningful effect
Scores use cautious estimates: results from observational studies are cut in half, and small or company-funded studies are discounted further. No option scored a 5.
Evidence bands
- Established: replicated, or from large, well-run trials or reviews.
- Emerging: real data in people, but early, small or not yet repeated.
- Theoretical: a plausible mechanism with little direct evidence for thinking or memory.
- Speculative: claims made without competent evidence.
Citations
| # | Citation | Link | Cited by |
|---|
Evidence reviewed November 2026. The three groups help you choose what to talk about; they are not a treatment recommendation for any one person. Every citation was checked against its publisher, Crossref or PubMed record.